Predictive Oncology Inc. Insider Trading for September 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Predictive Oncology Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Predictive Oncology Inc. for September 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 25 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
Sep 25 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 0.00 | 300,000 | 0 | 300,000 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 1.54 | 16,600 | 25,564 | 16,600 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | D | 7.48 | 16,600 | 124,168 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 1.54 | 30,411 | 46,833 | 30,411 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | D | 14.70 | 30,411 | 447,042 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 1.54 | 357 | 550 | 357 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | D | 41.98 | 357 | 14,985 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 1.54 | 14 | 22 | 14 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | D | 4,312.50 | 14 | 60,375 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 1.54 | 42 | 65 | 42 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | D | 1,481.25 | 42 | 62,213 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | A | 1.54 | 53 | 82 | 53 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | MYERS ROBERT L | Chief Financial Off ... | Option Exercise | D | 1,500.00 | 53 | 79,500 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 6,050 | 9,317 | 6,050 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 5.51 | 6,050 | 33,336 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 5,128 | 7,897 | 5,128 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 6.50 | 5,128 | 33,332 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 4,219 | 6,497 | 4,219 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 7.90 | 4,219 | 33,330 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 20,000 | 30,800 | 20,000 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 7.48 | 20,000 | 149,600 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 59 | 91 | 59 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 42.50 | 59 | 2,508 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 133 | 205 | 133 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 37.50 | 133 | 4,988 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 121 | 186 | 121 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 41.25 | 121 | 4,991 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 179 | 276 | 179 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 28.00 | 179 | 5,012 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 238 | 367 | 238 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 21.00 | 238 | 4,998 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 7 | 11 | 7 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 2,812.50 | 7 | 19,688 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 32,305 | 49,750 | 32,305 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 6.19 | 32,305 | 200,000 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 4,490 | 6,915 | 4,490 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 11.60 | 4,490 | 52,084 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 12,168 | 18,739 | 12,168 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 11.30 | 12,168 | 137,498 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 14,178 | 21,834 | 14,178 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 9.70 | 14,178 | 137,527 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 2,834 | 4,364 | 2,834 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 14.70 | 2,834 | 41,660 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 37,691 | 58,044 | 37,691 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 14.70 | 37,691 | 554,058 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 714 | 1,100 | 714 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 28.00 | 714 | 19,992 | 0 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | A | 1.54 | 52 | 80 | 52 | |
Sep 09 2020 | POAI | Predictive Oncolog ... | Schwartz Carl I. | Chief Executive Off ... | Option Exercise | D | 775.00 | 52 | 40,300 | 0 | |
Sep 02 2020 | POAI | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Buy | P | 0.90 | 4,000 | 3,602 | 12,070 | 8.1 K to 12.1 K (+49.57 %) |
Sep 02 2020 | POAI | Predictive Oncolog ... | GABRIEL RICHARD L | Director | Buy | P | 0.90 | 4,000 | 3,602 | 12,070 | 8.1 K to 12.1 K (+49.57 %) |